UBS Group’s IQ US Large Cap R&D Leaders ETF LRND Stock Holding History

UBS Group’s Portfolio LRND Stock Details LRND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-69	Closed	-$2.49K	–	10664
2025 Q2	$2.49K	Buy	69 +7	+11%	+$230	﹤0.01%	9457
2025 Q1	$1.99K	Hold	62	–	–	﹤0.01%	9416
2024 Q4	$2.12K	Buy	+62	New	+$2.11K	﹤0.01%	9107
2024 Q1	–	Sell	-4	Closed	-$113	–	9732
2023 Q4	$113	Buy	+4	New	+$105	﹤0.01%	8907

Other funds holding LRND

NYLIM

New York Life Investment Management New York $11.8B AUM 23.45% 1-Year Est. Return

GTS Securities New York $2.83B AUM 21.76% 1-Year Est. Return

UBS Group's LRND Position: Q3 2025 in Review

UBS Group sold out of IQ US Large Cap R&D Leaders ETF (LRND) in Q3 2025, closing a stake of 69 shares — an estimated $2.49K sold.

UBS Group first reported a position in LRND in Q4 2023 and held it in 4 quarters. The position peaked at $2.49K in Q2 2025. 2 funds tracked by Wall St. Rank hold LRND as of Q3 2025.

UBS Group reported no remaining IQ US Large Cap R&D Leaders ETF position as of Q3 2025 after selling out during the quarter.
UBS Group sold 69 IQ US Large Cap R&D Leaders ETF shares in Q3 2025, an estimated $2.49K.
UBS Group first reported a position in IQ US Large Cap R&D Leaders ETF in Q4 2023 and held it in 4 quarters.
UBS Group's IQ US Large Cap R&D Leaders ETF position peaked at $2.49K in Q2 2025.
2 funds tracked by Wall St. Rank held IQ US Large Cap R&D Leaders ETF as of Q3 2025.

Based on UBS Group's 13F filing for Q3 2025, filed 13 Nov 2025.